The therapeutic potential of targeting ABC transporters to combat multi-drug resistance.
about
The phytoestrogens daidzein and equol inhibit the drug transporter BCRP/ABCG2 in breast cancer cells: potential chemosensitizing effect.Altered membrane rigidity via enhanced endogenous cholesterol synthesis drives cancer cell resistance to destruxins.Cancer cell specific inhibition of Wnt/β-catenin signaling by forced intracellular acidification.Core signaling pathways in ovarian cancer stem cell revealed by integrative analysis of multi-marker genomics data.Clinical Significance of Organic Anion Transporting Polypeptide Gene Expression in High-Grade Serous Ovarian Cancer
P2860
The therapeutic potential of targeting ABC transporters to combat multi-drug resistance.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
The therapeutic potential of targeting ABC transporters to combat multi-drug resistance.
@en
The therapeutic potential of targeting ABC transporters to combat multi-drug resistance.
@nl
type
label
The therapeutic potential of targeting ABC transporters to combat multi-drug resistance.
@en
The therapeutic potential of targeting ABC transporters to combat multi-drug resistance.
@nl
prefLabel
The therapeutic potential of targeting ABC transporters to combat multi-drug resistance.
@en
The therapeutic potential of targeting ABC transporters to combat multi-drug resistance.
@nl
P2093
P2860
P1476
The therapeutic potential of targeting ABC transporters to combat multi-drug resistance
@en
P2093
Dong-Xu Liu
Fabrice Merien
Mingwei Chen
Piyush Bugde
Riya Biswas
Shufeng Zhou
P2860
P304
P356
10.1080/14728222.2017.1310841
P407
P50
P577
2017-04-03T00:00:00Z